Counting Offit's Millions: More on How Merck's Rotateq Vaccine Made Paul Offit Wealthy

By Dan Olmsted and Mark Blaxill Paul Offit, vaccine entrepreneur and public health spokesperson, has earned approximately $10 million in income from Rotateq® royalties through 2009 and stands to earn a total of between $13-35 million over the life of...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Nicaragua ,American ,Wyeth Rotashield ,Tamy Wallace ,Fred Clark ,Jake Crosby ,Russel Kaufman ,Merck Rotateq ,Wistar Rotateq ,Paul Offit ,Stanley Plotkin ,Offit Rotateq ,Staci Vernick Goldberg ,Glaxosmithkline Rotarix ,Merylej Melnicoff ,Growth Of The Wistar Institute Licensing Income ,Institute She ,Wistar Institute Annual ,Wistar Institute Technology ,Council For Growth ,Moody ,Children Hospital Foundation ,Moody Global Credit Research ,Royalty Pharma ,Paul Royalty Fund ,Paul Capital The Royalty Fund ,Wistar Institute ,Business Development ,Hospital Foundation ,Global Credit Research ,Inventor Share ,Intellectual Property ,Net Income ,Autism Contributing Editor Jake Crosby ,Applied Genomics ,Paul Capital ,Vernick Goldberg ,Annual Rotateq ,Annual Reports ,Wired Magazine ,Wall Street ,Like Wistar ,Total Payments ,Mark Blaxill ,Rotateq ,Merck ,Dan Olmsted ,Royalties ,Distar ,Shop ,Payments ,Age Of Autism ,